Please welcome our newest faculty member, Professor Zhen Gu, to the Department of Bioengineering and the California Nanosystems Institute. Gu’s research is based on controlled drug delivery, bio-inspired materials and nanobiotechnology, especially for cancer and diabetes treatment.
He has received many honors for his work, including the Sloan Research Fellowship, Young Investigator Award of the Controlled Release Society (CRS), Pathway Award of the American Diabetes Association, Biomaterials Science Lectureship Award, and Young Innovator Award in Cellular and Molecular Engineering of the Biomedical Engineering Society. MIT Technology Review has listed him as one of the global top innovators under the age of 35 (TR35). He has published over 140 research papers and applied over 50 patents. He is a co-founder of three start-up companies. He serves as an Associate Editor for Nano Research and Focus Group Chair of Bio-inspired and Biomimetic Drug Delivery (BBDD) in CRS. Before he joins UCLA on July 1, Gu has been named the Jackson Family Distinguished Professor in the Joint Department of Biomedical Engineering at the University of North Carolina at Chapel Hill and North Carolina State University. He received his Ph.D. from UCLA, under the guidance of Dr. Yi Tang in the Department of Chemical and Biomolecular Engineering in 2010. He was a Postdoctoral Associate working with Dr. Robert Langer and Dr. Daniel Anderson at MIT and Harvard Medical School during 2010 to 2012.
For more information about Professor Gu and his research, please visit his faculty page: https://www.bioeng.ucla.edu/zhen-gu-ph-d/